Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

the ADVANCE Collaborative Group·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0802987

Cited by (1,093)

Items 601–700 of 1,093

  1. Diagnosis and Treatment of Type 2 Diabetes in Adults
    Kalyani, Rita R., Neumiller, Joshua J., Maruthur, Nisa M., Wexler, Deborah J. · 2025 · JAMA
  2. Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
    Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Journal of Cardiac Failure
  3. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
    Joshua J. Neumiller · 2009 · Journal of the American Pharmacists Association
  4. Diabetes and Hypertension: A Comparative Review of Current Guidelines
    Michael Cryer, Tariq Horani, Donald J. DiPette · 2015 · Journal of Clinical Hypertension
  5. Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial
    Julio Rosenstock, Nikolaus Marx, Steven E. Kahn, Bernard Zinman, John J.P. Kastelein, John M. Lachin, Erich Bluhmki, Sanjay Dhanji Patel, Odd-Erik Johansen, H.J. Woerle · 2013 · Diabetes and Vascular Disease Research
  6. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
    Muhammad A. Abdul-Ghani, Ralph Anthony DeFronzo, Stefano Del Prato, ROBERT J. CHILTON, Rajvir Singh, Robert E. J. Ryder · 2017 · Diabetes Care
  7. Management of hypoglycemia in older adults with type 2 diabetes
    Jeffrey S. Freeman · 2019 · Postgraduate Medicine
  8. Management of diabetes mellitus in patients with chronic kidney disease
    Hahr, Allison J., Molitch, Mark E. · 2015 · Clinical Diabetes and Endocrinology
  9. Night Time Blood Pressure Variability Is a Strong Predictor for Cardiovascular Events in Patients With Type 2 Diabetes
    Katsumi Eguchi, Joji Ishikawa, Satoshi Hoshide, Thomas G. Pickering, Joseph E. Schwartz, Kazuyuki Shimada, Kazuomi Kario · 2008 · American Journal of Hypertension
  10. Renal and Cardiac Effects of DPP-4 Inhibitors – from Preclinical Development to Clinical Research
    Berthold Hocher, Christoph Reichetzeder, Markus Alter · 2012 · Kidney & Blood Pressure Research
  11. Personalized Management of Hyperglycemia in Type 2 Diabetes
    Itamar Raz, Matthew C. Riddle, Julio Rosenstock, John B. Buse, Silvio E. Inzucchi, Philip Home, Stefano Del Prato, Ele Ferrannini, Juliana C.N. Chan, Lawrence A. Leiter et al. · 2013 · Diabetes Care
  12. Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
    Jeffrey A. Johnson, Samantha L. Bowker · 2010 · Diabetologia
  13. The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence
    Charles Nordin · 2010 · Diabetologia
  14. Effects of Intensive Glucose Lowering in Type 2 Diabetes
    Sven Schinner · 2009 · Yearbook of Endocrinology
  15. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
    Linda A. Gallo, Micheal S. Ward, Amelia K. Fotheringham, Aowen Zhuang, Danielle J. Borg, Nicole Flemming, Ben M. Harvie, Toni L. Kinneally, Shang-Ming Yeh, Domenica A. McCarthy et al. · 2016 · Scientific Reports
  16. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach
    Lorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto, Andrea Natali · 2020 · Cardiovascular Diabetology
  17. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
    McCoy, Rozalina G., Lipska, Kasia J., Yao, Xiaoxi, Ross, Joseph S., Montori, Victor M., Shah, Nilay D. · 2016 · JAMA Internal Medicine
  18. Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality*
    Yaseen M. Arabi, Hani Tamim, Asgar H. Rishu · 2009 · Critical Care Medicine
  19. Advances in the Medical Treatment of Diabetic Retinopathy
    Rafael Simó, Cristina Hernández · 2009 · Diabetes Care
  20. Macrophage metabolism in atherosclerosis
    Bories, Gael F. P., Leitinger, Norbert · 2017 · FEBS Letters
  21. Chapter 3: Management of progression and complications of CKD
    2012 · Kidney International Supplements
  22. Risk of Hypoglycemia in Older Veterans with Dementia and Cognitive Impairment: Implications for Practice and Policy
    Denise G. Feil, Mangala Rajan, Orysya Soroka, Chin‐Lin Tseng, Donald R. Miller, LEONARD M. POGACH · 2011 · Journal of the American Geriatrics Society
  23. Death during intensive glycemic therapy of diabetes: mechanisms and implications
    Cryer, Philip E. · 2011 · The American Journal of Medicine
  24. Oral insulin – a review of current status
    Harish V Iyer, Anand Khedkar, Manish Verma · 2009 · Diabetes Obesity and Metabolism
  25. KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
    MARGARET JOHNSON BIA, Deborah Adey, Roy D. Bloom, Laurence K. Chan, Sanjay Kulkarni, Steven Tomlanovich · 2010 · American Journal of Kidney Diseases
  26. Glucagon‐like peptide‐1‐based therapies and cardiovascular disease: looking beyond glycaemic control
    Panagiotis G. Anagnostis, Vasilios Gabriel Athyros, Fotini Adamidou, Alexandra Panagiotou, Marina D. Kita, Asterios I. Karagiannis, Dimitri P. Mikhailidis · 2010 · Diabetes Obesity and Metabolism
  27. Effects of Bilio-Pancreatic Diversion on Diabetic Complications
    Amerigo Iaconelli, Simona Panunzi, Andrea De Gaetano, Melania Manco, Caterina Guidone, Laura Leccesi, Donatella Gniuli, G Nanni, Marco Castagneto, Giovanni Ghirlanda et al. · 2011 · Diabetes Care
  28. Diabetic nephropathy
    Themis Zelmanovitz, Fernando Gerchman, Amely Ps Balthazar, Fúlvio Clemo Santos Thomazelli, Jorge Dias de Matos, Luís Henrique Santos Canani · 2009 · Diabetology & Metabolic Syndrome
  29. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011
    Pathak, Ram D., Schroeder, Emily B., Seaquist, Elizabeth R., Zeng, Chan, Lafata, Jennifer Elston, Thomas, Abraham, Desai, Jay, Waitzfelder, Beth, Nichols, Gregory A., Lawrence, Jean M. et al. · 2016 · Diabetes Care
  30. Diabetic cardiomyopathy: prevalence, determinants and potential treatments
    Gaurav Singh Gulsin, Lavanya Athithan, Gerry Patrick McCann · 2019 · Therapeutic Advances in Endocrinology and Metabolism
  31. The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
    Dhatariya, Ketan, Bain, Stephen C., Buse, John B., Simpson, Richard, Tarnow, Lise, Kaltoft, Margit Staum, Stellfeld, Michael, Tornøe, Karen, Pratley, Richard E., the LEADER Publication Committee on behalf of the LEADER Trial Investigators · 2018 · Diabetes Care
  32. Epigenetic Changes in Diabetes and Cardiovascular Risk
    Keating, Samuel T., Plutzky, Jorge, El-Osta, Assam · 2016 · Circulation Research
  33. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
    William David Strain, Valentina Lukashevich, Wolfgang Kothny, Marie-José Hoellinger, Päivi Maria Paldánius · 2013 · The Lancet
  34. Complementary and alternative medicine for the treatment of type 2 diabetes.
    Richard Nahas, Matthew Moher · 2009 · PubMed Central
  35. Vascular ageing: moving from bench towards bedside
    Rachel E. Climie, Jordi Alastruey, Christopher Clemens Mayer, Achim Schwarz, Agnė Laučytė-Cibulskienė, Jūlija Voicehovska, Elisabetta Bianchini, Rosa María Bruno, Peter H Charlton, Andrea Grillo et al. · 2023 · European Journal of Preventive Cardiology
  36. Metabolic diseases and associated complications: sex and gender matter
    Kautzky‐Willer, A., Handisurya, A. · 2009 · European Journal of Clinical Investigation
  37. Pharmacologic management of type 2 diabetes
    Harper, William, Clement, Maureen, Goldenberg, Ronald, Hanna, Amir, Main, Andrea, Retnakaran, Ravi, Sherifali, Diana, Woo, Vincent, Yale, Jean-François · 2013 · Canadian Journal of Diabetes
  38. Novel therapies with precision mechanisms for type 2 diabetes mellitus
    Leigh Perreault, Jay S. Skyler, Julio Rosenstock · 2021 · Nature Reviews Endocrinology
  39. Vascular complications of diabetes: A narrative review
    Yongxia Lu, Wei Wang, Jingyu Liu, Min Xie, Qiang Liu, Sufang Li · 2023 · Medicine
  40. Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress
    Jingli Wang, Anna Alexanian, Rong Ying, Tinoy J. Kizhakekuttu, Kodlipet Dharmashankar, Jeanette Vasquez-Vivar, David D. Gutterman, Michael E. Widlansky · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  41. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
    Massimo Francesco Piepoli, Arno Wilhelmus Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Alberico Luigi Catapano, Marie Therese Cooney, Ugo Corrà, Bernard Cosyns, Christi Deaton et al. · 2016 · Kardiologia Polska
  42. Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?
    Katina D. Hulme, Linda A. Gallo, Kirsty Renfree Short · 2017 · Frontiers in Microbiology
  43. Epigenetics in the pathogenesis of diabetic nephropathy
    Xue Li, Lihong Lu, Wenting Hou, Ting Huang, Xiangyuan Chen, Jie Qi, Yanjun Zhao, Minmin Zhu · 2021 · Acta Biochimica et Biophysica Sinica
  44. Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk
    The FLAT-SUGAR Trial Investigators · 2016 · Diabetes Care
  45. Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
    Michal P. Nowicki, Ivan Rychlík, Hermann G. Haller, Mark Warren, Lisa J. Suchower, Ingrid A. M. Gause‐Nilsson, K-M. Schützer · 2011 · International Journal of Clinical Practice
  46. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
    John‐Michael Gamble, Scot H. Simpson, Dean T. Eurich, Sumit R. Majumdar, Jeffrey A. Johnson · 2009 · Diabetes Obesity and Metabolism
  47. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
    Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Tomio Onuma, Nobuichi Kuribayashi, Takeshi Osonoi, Hideaki Kaneto, Keisuke Kosugi, Yutaka Umayahara et al. · 2016 · Diabetes Care
  48. Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery
    Chaim M. Bell · 2009 · JAMA
  49. Computer Modeling of Diabetes and Its Complications: A Report on the Fifth Mount Hood Challenge Meeting
    Andrew John Palmer · 2013 · Value in Health
  50. Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes
    Elizabeth Selvin, Ning Yang, Michael W. Steffes, Lori D. Bash, Ronald Klein, Tien Yin Wong, Brad C. Astor, Albert Richey Sharrett, Frederick L. Brancati, Josef Coresh · 2010 · Diabetes
  51. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus
    Melissa Leung, Vincent Wai‐Sun Wong, Harold Malcolm Hudson, Dominic Y. Leung · 2016 · Circulation Cardiovascular Imaging
  52. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
    Koska, Juraj, Saremi, Aramesh, Howell, Scott, Bahn, Gideon, De Courten, Barbora, Ginsberg, Henry, Beisswenger, Paul J., Reaven, Peter D., for the VADT Investigators · 2018 · Diabetes Care
  53. Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
    Meg Jardine, Jun Hata, Mark Woodward, Vlado Perkovic, Toshiharu Ninomiya, Hisatomi Arima, Sophia Zoungas, Alan Cass, Anushka A Patel, Michel Marre et al. · 2012 · American Journal of Kidney Diseases
  54. Diabetes Performance Measures: Current Status and Future Directions
    Patrick J. O’Connor, Noni L. Bodkin, JUDITH E. FRADKIN, Russell E. Glasgow, Sheldon Greenfield, Edward W. Gregg, Eve A. Kerr, L. Gregory Pawlson, Joseph V. Selby, John E. Sutherland et al. · 2011 · Diabetes Care
  55. CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE
    M. Patrice Lindsay · 2013
  56. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack
    Yongjun Wang, Ming Liu, Chuanqiang Pu · 2017 · International Journal of Stroke
  57. Documento de consenso para la detección y manejo de la enfermedad renal crónica
    Alberto Martínez‐Castelao, José Luis Górriz, Jordi Bover, Julián Segura-de la Morena, Jesús Cebollada, Javier Escalada, Enric Esmatjes, Lorenzo Fácila, Javier Gamarra, Sílvia Gràcia et al. · 2014 · Atención Primaria
  58. Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
    Daniel T. Lackland, Mitchell S.V. Elkind, Ralph B. D’Agostino, Mandip S. Dhamoon, David Calvin Goff, Randall T. Higashida, Leslie Ain McClure, Pamela H. Mitchell, Ralph L. Sacco, Cathy A. Sila et al. · 2012 · Stroke
  59. Postprandial hyperglycemia on vascular endothelial function: mechanisms and consequences.
    E. Mah, Richard S. Bruno · 2012 · Nutrition Research
  60. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system
    Jean‐Pierre Riveline, Julie Teynie, S. Belmouaz, Sylvia Franc, Dured Dardari, Marc Bauwens, Valérie Caudwell, Stéphanie Ragot, Frank Bridoux, Guillaume Charpentier et al. · 2009 · Nephrology Dialysis Transplantation
  61. Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular Outcomes in Diabetic Patients with Acute Myocardial Infarction
    Marianne Zeller, Nicolas Danchin, D. Simon, Alec S. Vahanian, Luc Lorgis, Yves Cottin, Jacques Berland, Pascal Guéret, Pascal Wyart, Régis Deturck et al. · 2010 · The Journal of Clinical Endocrinology & Metabolism
  62. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study
    for the ADVANCE Collaborative Group, André Pascal Kengne, Anushka A Patel, Stephen Colagiuri, Simon R. Heller, Pavel Hamet, Michel Marre, Changyu Pan, Sophia Zoungas, Diederick E. Grobbee et al. · 2010 · Diabetologia
  63. Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction
    Mikhail Kosiborod, Silvio E. Inzucchi, Harlan M. Krumholz, Frederick A. Masoudi, Abhinav Goyal, Lan Xiao, Philip G. Jones, Suzanne Fiske, John A. Spertus · 2009 · Archives of Internal Medicine
  64. Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
    Pratley, Richard E., Tuttle, Katherine R., Rossing, Peter, Rasmussen, Søren, Perkovic, Vlado, Nielsen, Olav Wendelboe, Mann, Johannes F.E., MacIsaac, Richard J., Kosiborod, Mikhail N., Kamenov, Zdravko et al. · 2024 · Journal of the American College of Cardiology
  65. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study
    Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., Charbonnel, B. · 2015 · Diabetes & Metabolism
  66. Epigenetic programming, early life nutrition and the risk of metabolic disease
    Block, Tomasz, El-Osta, Assam · 2017 · Atherosclerosis
  67. Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
    Perreault, Leigh, Temprosa, Marinella, Mather, Kieren J., Horton, Ed, Kitabchi, Abbas, Larkin, Mary, Montez, Maria G., Thayer, Debra, Orchard, Trevor J., Hamman, Richard F. et al. · 2014 · Diabetes Care
  68. Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial
    Ann V. Schwartz, Karen L. Margolis, Deborah E. Sellmeyer, Eric Vittinghoff, Walter T. Ambrosius, Denise E. Bonds, Robert G. Josse, Adrian M. Schnall, Debra L. Simmons, Trisha F. Hue et al. · 2012 · Diabetes Care
  69. Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
    Fonseca, Vivian A., Handelsman, Yehuda, Staels, Bart · 2010 · Diabetes, Obesity and Metabolism
  70. Targets for Glycemic Control
    S. Ali Imran, RÉMI P.R. RABASA-LHORET, Stuart A. Ross · 2013 · Canadian Journal of Diabetes
  71. Megatrials in type 2 diabetes. From excitement to frustration?
    Stefano Del Prato · 2009 · Diabetologia
  72. 9. Microvascular Complications and Foot Care
    American Diabetes Association · 2015 · Diabetes Care
  73. Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
    Lind, Marcus, Imberg, Henrik, Coleman, Ruth L., Nerman, Olle, Holman, Rury R. · 2021 · Diabetes Care
  74. The HbA1c and All-Cause Mortality Relationship in Patients with Type 2 Diabetes is J-Shaped: A Meta-Analysis of Observational Studies
    Luke W. Arnold, Zhiqiang Wang · 2014 · The Review of Diabetic Studies
  75. Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.
    Brendan McIntosh, Chris G Cameron, Sumeet R. Singh, Changhua Yu, Tarun K. Ahuja, Nicky J. Welton, Marshall Dahl · 2011 · Europe PMC (PubMed Central)
  76. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease
    Stephanie A. Ross, Hertzel C. Gerstein, John W. Eikelboom, Sonia Savitri Anand, Salim Yusuf, Guillaume Paré · 2015 · European Heart Journal
  77. Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial
    Michael E. Miller, Jeff D. Williamson, Hertzel C. Gerstein, Robert P. Byington, William C. Cushman, Henry N. Ginsberg, Walter T. Ambrosius, Laura Lovato, William B. Applegate, for the ACCORD Investigators · 2013 · Diabetes Care
  78. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome
    Rim Hasan, Belal Firwana, Tarig A. Elraiyah, Juan Pablo Domecq, Gabriela J. Prutsky, Mohammed Nabhan, Larry J. Prokop, Peter K. Henke, Απόστολος Τσάπας, Víctor M. Montori et al. · 2016 · Journal of Vascular Surgery
  79. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases
    Aikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, Marco Meloni, Renato Lauro, David Della‐Morte, Davide Lauro · 2021 · Current Opinion in Pharmacology
  80. Multifactorial intervention in diabetes care using real-time monitoring and tailored feedback in type 2 diabetes
    Soo Kyung Lim, Seon Mee Kang, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Hee Young Hwang, Hye Seung Jung, Kyong Soo Park, Jun Oh Ryu, Hak Chul Jang · 2015 · Acta Diabetologica
  81. Exercise therapy in Type 2 diabetes
    Stephan Praet, Luc J. C. van Loon · 2009 · Acta Diabetologica
  82. Blood pressure control for diabetic retinopathy
    V. Diana, Xue Wang, Satyanarayana Swaroop Vedula, Michael T. Marrone, Gina G. Sleilati, Barbara S. Hawkins, Robert N. Frank · 2015 · Cochrane Database of Systematic Reviews
  83. Diabetic autonomic neuropathy
    Aaron I. Vinik, Tomris A Erbas · 2013 · Handbook of clinical neurology
  84. Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review
    Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., Mannino, D. · 2020 · Diabetology & Metabolic Syndrome
  85. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
    American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
  86. Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
    George L. Bakris · 2011 · Mayo Clinic Proceedings
  87. Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
    Edoardo Mannucci, Ilaria Dicembrini, Angelo Lauria, Paolo Pozzilli · 2013 · Diabetes Care
  88. Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
    Daniela Impellizzeri, Emanuela Esposito, James Attley, Salvatore Cuzzocrea · 2014 · Pharmacological Research
  89. Type 2 diabetes and cardiovascular disease in women
    Anna Norhammar, Karin G. Schenck-Gustafsson · 2012 · Diabetologia
  90. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Tim Heise, LEO J. SEMAN, Sreeraj Macha, Peter Jones, Alexandra Marquart, Sabine Pinnetti, Hans Juergen Woerle, Klaus A. Dugi · 2013 · Diabetes Therapy
  91. Prevention, management, and rehabilitation of stroke in low- and middle-income countries
    Lijing L. Yan, Chaoyun Li, Jie Chen, J. Jaime Miranda, Rong Luo, Janet Prvu Bettger, Yishan Zhu, Valery L. Feigin, Martin James O'Donnell, Dong Zhao et al. · 2016 · eNeurologicalSci
  92. Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
    Xinlin Zhang, Qingqing Zhu, Yuhan Chen, Xueling Li, Fu Chen, Jianan Huang, Biao Xu · 2018 · Journal of the American Heart Association
  93. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
    Stephen N. Davis, William C. Duckworth, Nicholas Emanuele, Rodney A. Hayward, Wyndy L. Wiitala, Lizy Thottapurathu, Domenic J. Reda, Peter D. Reaven · 2018 · Diabetes Care
  94. Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 Diabetes
    Sara Kazempour‐Ardebili, Varunika L. Lecamwasam, Thushara Dassanyake, Andrew Frankel, Frederick W.K. Tam, Anne Dornhorst, Gary Steven Frost, Jeremy J. O. Turner · 2009 · Diabetes Care
  95. Nuts, metabolic syndrome and diabetes
    Kendall, Cyril W. C., Josse, Andrea R., Esfahani, Amin, Jenkins, David J. A. · 2010 · British Journal of Nutrition
  96. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
    Daniel S Lasserson, Paul Glasziou, Rafael Perera, Rury R. Holman, Andrew A. Farmer · 2009 · Diabetologia
  97. DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results
    John B. Buse, Bruce H. R. Wolffenbuttel, William H. Herman, Natalie K. Shemonsky, Honghua H. Jiang, Jessie L. Fahrbach, Jamie L. Scism-Bacon, Sherry Martin · 2009 · Diabetes Care
  98. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study
    Lena M. S. Carlsson, Kajsa Sjöholm, Cecilia Karlsson, Peter Jacobson, Johanna C. Andersson‐Assarsson, Per‐Arne Svensson, Ingrid Larsson, Stephan Hjorth, Martin Neovius, Magdalena Taube et al. · 2017 · The Lancet Diabetes & Endocrinology
  99. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
    E. Wan, C. Fung, F. Jiao, E. Yu, Weng Y. Chin, D. Fong, C. Wong, A. K. L. Chan, K. H. Chan, R. Kwok et al. · 2017 · Diabetes Care
  100. Pathogenesis of Cardiovascular Disease in Diabetes
    Andrea V Haas, Marie Elizabeth McDonnell · 2018 · Endocrinology and Metabolism Clinics of North America